首页> 外文期刊>Surgical oncology >Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?
【24h】

Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?

机译:右侧与左侧结肠癌患者较低的生存率:答案是延长的淋巴结切除术后答案吗?

获取原文
获取原文并翻译 | 示例
           

摘要

IntroductionTumour location may affect oncologic outcomes for colon adenocarcinoma due to different levels of vascular ligation and nodal harvest, but the data are equivocal. The objective of this study is to determine the effect of tumor location and lymph node yield on overall survival(OS) in stage I-III colon adenocarcinoma. MethodsThe 2004–2014 National Cancer Database was queried for colectomies for non-metastatic colon adenocarcinoma, excluding transverse colon and rectal cancer. Patients were grouped based on left/right tumor location. Main outcome measure was 5-year OS. Propensity score matching created balanced cohorts. Multilevel survival analysis determined the independent effect of tumor location and nodal harvest on OS. ResultsThere were 504,958 patients (273,198 right; 231,760 left) in the entire cohort: 26.4% stage-I, 37.3% stage-II, and 36.3% stage-III (equal distribution left/right). After 1:1 matching(n?=?297,080), right cancers were associated with worse 5-year overall survival for stage-II (66% vs. 70%,p? 22 lymph node harvest towards increased survival (HR 0.86, 95%CI 0.80–0.92). ConclusionsRight-sided cancers are associated with worse oncologic outcomes compared to left-sided tumors but a higher lymph node yield improves survival. These data provide indirect evidence for a higher lymphatic harvest to improve survival.
机译:由于不同水平的血管结扎和节点收获,引入技术可能会影响结肠腺癌的肿瘤结果,但数据是等因素的。本研究的目的是确定肿瘤位置和淋巴结产量在第I-III阶段结肠腺癌中整体存活率(OS)的影响。方法对于非转移性结肠癌腺癌的联合膜,不包括横向结肠癌和直肠癌,询问了2004-2014国家癌症数据库。患者基于左/右肿瘤位置进行分组。主要结果措施是5年的操作系统。倾向得分匹配创造了平衡队列。多级存活分析确定了肿瘤位置的独立效应和核心核桃瘤。结果是504,958名患者(273,198右; 231,760左),在整个队列中:26.4%阶段-i,37.3%阶段-II和36.3%阶段-III(左/右等分布)。 1:1匹配(n?= 297,080),右癌症与阶段-II的较差的5年总生存率有关(66%对70%,p?22淋巴结收获增加生存(HR 0.86,95 %CI 0.80-0.92)。与左侧肿瘤相比,结论术语癌症与较差的肿瘤结果相关,但淋巴结产量更高,提高了生存率。这些数据为提高生存率提供了更高的淋巴收获的间接证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号